“Intrauterine Misoprostol Versus Intravenous Oxytocin for the Prevention of Primary Postpartum Hemorrhage During Cesarean Section: A One-Year Randomized Controlled Trial” (2026) Eastern Medical College Journal, 10(2), pp. 111–115. doi:10.3329/emcj.v10i2.85706.